Pain management drugs market to reach $108.86 billion by 2030 at 5.1% cagr, driven by rise in the geriatric population globally.
Read More
Pain management market to reach $96 billion by 2030 at 4.4% cagr, driven by rising prevalence of chronic pain conditions across populations.
Read More
Paclitaxel injection market to reach $12.72 billion by 2030 at 13.4% cagr, driven by growing incidence of breast cancer and overall cancer cases.
Read More
Oxycodone hydrochloride market to reach $5.18 billion by 2030 at 3.6% cagr, driven by increasing prevalence of chronic pain worldwide.
Read More
Oxycodone drugs market to reach $8.07 billion by 2030 at 6.1% cagr, driven by rising burden of orthopedic disorders and chronic pain conditions.
Read More
Ovulation inducing drugs market to reach $6.62 billion by 2030 at 7.3% cagr, driven by increasing prevalence of women’s infertility globally.
Read More
Over the counter vitamins and minerals dietary supplements market to reach $73.4 billion by 2030 at 6.1% cagr, driven by growing awareness of preventive healthcare.
Read More
Over the counter sleep aids medication market to reach $33.15 billion by 2030 at 7.8% cagr, driven by rising prevalence of insomnia and growing stress levels.
Read More
Over the counter probiotics supplements market to reach $12.1 billion by 2030 at 11.0% cagr, driven by increasing prevalence of digestive disorders worldwide.
Read More
Over the counter diet products market to reach $213.26 billion by 2030 at 8.5% cagr, driven by rising health consciousness and proactive weight management trends.
Read More